Full name
GUERBET POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 0,6 | 0,5 | -12,8 |
EBITDA | 1,1 | 0,6 | 0,7 | 7,2 |
Short time liabilities | 0,6 | 0,5 | 0,5 | -8,7 |
Equity capital | 2,9 | 2,2 | 1,5 | -32,5 |
Operating profit (EBIT) | 1 | 0,5 | 0,6 | 10,2 |
Assets | 4,5 | 3,6 | 3,3 | -10 |
Net profit (loss) | 0,9 | 0,2 | 0,3 | 34,5 |
Cash | 0,4 | 0,5 | 0,4 | -7,6 |
Net income from sale | 8,3 | 8,1 | 9,8 | 21,3 |
Liabilities and provisions for liabilities | 1,6 | 1,4 | 1,7 | 27 |
Working assets | 4 | 3,1 | 2,7 | -13,5 |
Depreciation | 0,1 | 0,1 | 0,1 | -5,6 |
% | % | % | p.p. | |
Profitability of capital | 29,7 | 8,9 | 17,8 | 8,9 |
Equity capital to total assets | 65 | 62,1 | 46,5 | -15,6 |
Gross profit margin | 11,9 | 6,8 | 4,9 | -1,9 |
EBITDA Margin | 12,7 | 7,6 | 6,7 | -0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 23 | 17 | -6 |
Current financial liquidity indicator | 2.5779898166656494 | 2.2626960277557373 | 1.54006028175354 | -0,8 |
Net dept to EBITDA | -0.3877883851528168 | -0.7479814291000366 | -0.6442937850952148 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane